Patients with T2DM who have never been administered GLP-1 RAs and have an HDL-cholesterol level of 46 mg/dL or higher may be the most suitable candidates for weight reduction with 1.0 mg semaglutide weekly. Here, GLP1R is linked to type 2 diabetes mellitus.